Pardeep Nijhawan - Aug 4, 2023 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Signature
/s/ Pardeep Nijhawan
Stock symbol
EDSA
Transactions as of
Aug 4, 2023
Transactions value $
$0
Form type
4
Date filed
8/4/2023, 04:18 PM
Previous filing
Jul 24, 2023
Next filing
Jan 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDSA Common Shares Award +99.3K +16.69% 694K Aug 4, 2023 Direct F1
holding EDSA Common Shares 2.36M Aug 4, 2023 Held by Pardeep Nijhawan Medicine Professional Corporation F2
holding EDSA Common Shares 228K Aug 4, 2023 By The New Nijhawan Family Trust 2015 F3
holding EDSA Common Shares 224K Aug 4, 2023 Held by The Digestive Health Clinic Inc. F2
holding EDSA Common Shares 372K Aug 4, 2023 Held by 1968160 Ontario Inc. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted share units ("RSUs"), which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of a portion of Reporting Person's cash bonus earned for the calendar year ending December 31, 2022. The number of RSUs was determined by dividing such portion of the cash bonus by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through July 31, 2023.
F2 Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.